1.Liu S, Huang R, Li A, Yu S, Yao S, Xu J, Tang L, Li W, Gan C, Cheng H. Effects of the CALM intervention on resilience in Chinese patients with early breast cancer: a randomized trial. J Cancer Res Clin Oncol. 2023 Dec;149(20):18005-18021.（IF 2.7）
2. Li W, Gan C, Yu S, Xu J, Tang L, Li Q, Zhu Z, Cheng H. GSK3β rs3107669 polymorphism implicates chemotherapy-associated retrospective memory deficits in breast cancer survivors. Am J Cancer Res. 2023 Oct 15;13(10):4961-4975. （IF 3.6）
3. Zhang Y, Gan C, Xu J, Pang L, Li W, Cheng H. Psychological distress as a risk factor for the efficacy of chemotherapy in advanced gastric cancer patients. Support Care Cancer. 2023 Nov 3;31(12):669. （IF 2.8）
4. Liu S, Huang R, Li A, Yu S, Yao S, Xu J, Tang L, Li W, Gan C, Cheng H. The role of the oxytocin system in the resilience of patients with breast cancer. Front Oncol. 2023 Sep 13;13:1187477. （IF 3.5）
5. Liu S, Jia Y, Chai J, Ge H, Huang R, Li A, Cheng H. A Predictive Model for the Early Death of Breast Cancer With Synchronous Liver Metastases: A Population-Based Study. Cancer Control. 2023 Jan-Dec;30:10732748231202851. （IF 2.6）
6. Gan C, Li W, Xu J, Pang L, Tang L, Yu S, Li A, Ge H, Huang R, Cheng H. Advances in the study of the molecular biological mechanisms of radiation-induced brain injury. Am J Cancer Res. 2023 Aug 15;13(8):3275-3299. （IF 3.6）
7. Duan X, Jia Y, Chai J, Li W, Tang L, Li A, Ge H, Huang R, Cheng H. Music therapy, quality of life and efficacy of immunotherapy for NSCLC. BMJ Support Palliat Care. 2023 Sep 6:spcare-2023-004325. （IF 1.9）
8. Wang M, Gan C, Zhao J, Li W, Yu S, Yao S, Tang L, Xu J, Cheng H. Positive influence of managing cancer and living meaningfully (CALM) on fear of cancer recurrence in breast cancer survivors. Am J Cancer Res. 2023 Jul 15;13(7):3067-3079. （IF 3.6）
9. Yu S, Tang L, Zhang Q, Li W, Yao S, Cai Y, Cheng H. A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma. Hereditas. 2023 Jul 24;160(1):31. doi: 10.1186/s41065-023-00293-w. （IF 2.1）
10. Cai Y, Zhao J, Li W, Yu S, Tang L, Yao S, Cheng H. The effects of Managing Cancer and Living Meaningfully (CALM) on psychological distress in esophageal cancer patients. Future Oncol. 2023 Jun;19(19):1357-1366. （IF 3.5）
11. Zhao J, Wang M, Huang R, Xu J, Gan C, Yu S, Tang L, Yao S, Li W, Cheng H. Effects of CALM intervention on neutrophil-to-lymphocyte ratio (NLR), fear of cancer recurrence and quality of life in patients with lung cancer. Support Care Cancer. 2023 Jan 17;31(2):121. （IF 2.8）
12. Yao S, Zhu Q, Zhang Q, Cai Y, Liu S, Pang L, Jing Y, Yin X, Cheng H. Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI. Cancer Med. 2023 Aug;12(15):16231-16242. （IF 2.9）
13. Yao S, Zhang Q, Yao X, Zhang X, Pang L, Yu S, Cheng H. Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer. Breast Cancer Res Treat. 2023 Aug;201(1):15-26. （IF 3.0）
14. Zhang Q, Cai Y, Yu S, Tang L, Li W, Yao S, Zheng X, Liu J, Chen G, Gan C, Xu J, Cheng H. Effects of fear of cancer recurrence on subjective physical and mental health in breast cancer patients: The intermediary role of heart rate variability. Cancer Med. 2023 Aug;12(15):16570-16579. （IF 2.9）
15. Cai Y, Zhang Q, Gan C, Xu J, Yu S, Tang L, Yao S, Li W, Huang R, Cheng H. Effects of Managing Cancer and Living Meaningfully on Cancer-Related Fatigue and Cytokine Levels in Gastrointestinal Cancer Patients. Integr Cancer Ther. 2023 Jan-Dec;22:15347354231172511. （IF 2.9）
16. Pang L, Li W, Yao S, Jing Y, Yin X, Cheng H. Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels. Cancer Med. 2023 May;12(10):11806-11815. （IF 2.9）
17. Yao S, Chen W, Chen T, Zuo H, Bi Z, Zhang X, Pang L, Jing Y, Yin X, Cheng H. A comprehensive computational analysis to explore the importance of SIGLECs in HCC biology. BMC Gastroenterol. 2023 Feb 18;23(1):42. doi: 10.1186/s12876-023-02672-z. （IF 2.5）
18. Li W, Gan C, Zuo H, Yin X, Jing Y, Pang L, Yu S, Tang L, Yao S, Cheng H. Psychological distress as risk factor for the efficacy of whole-brain radiotherapy in brain metastasis patients. Future Oncol. 2023 Jan;19(1):49-60. doi: 10.2217/fon-2022-0690. （IF 3.0）
19. Pang L, Yao S, Li W, Jing Y, Yin X, Cheng H. Impact of the CALM intervention on breast cancer patients during the COVID-19 pandemic. Support Care Cancer. 2023 Jan 17;31(2):121. doi: 10.1007/s00520-023-07582-0. （IF 2.8）
20. Yu S, Li W, Tang L, Fan X, Yao S, Zhang X, Bi Z and Cheng H. Depression in breast cancer patients: Immunopathogenesis and immunotherapy. Cancer Letter 2022; 536: 215648. （IF 9.756）
21. Li W, Bi Z, Wu J, Duan X, Pang L, Jing Y, Yin X, Cheng H. Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients. Frontiers in Oncology, Front Oncol. 2022,12:772102（IF 6.244）
22. Li W, Zhang Q, Cai Y, Chen T and Cheng H. The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2-/+ Breast Cancer. Frontiers in Oncology 2022; 12: 816923. （IF 6.244）
23. Bi Z, Li W, Zhao J, Pang L, Jing Y, Zhang X, Yao S, Yin X, Zuo H and Cheng H. Negative correlations of psychological distress with quality of life and immunotherapy efficacy in patients with advanced NSCLC. Amercian Journal of Cancer Research, 2022; 12: 805-815.（IF 6.166）
24. Li W, Yu S, Duan X, Yao S, Tang L and Cheng H. COMT rs737865 mediates chemobrain in breast cancer patients with various levels of Ki-67. Amercian Journal of Cancer Research, 2022. (IF 6.166)
25. Zhang X, Yao S, Wang M, Yin X, Bi Z, Jing Y and Cheng H. The Impact of VR-CALM Intervention Based on VR on Psychological Distress and Symptom Management in Breast Cancer Survivors. Journal of Oncology. 2022. (IF 4.375 )
26. Jing Y, Zhao J, Yang Z, Yao S, Tang L, Li W, Yu S and Cheng H, Managing cancer and living meaningfully (CALM) as an intervention for severe fatigue in gastrointestinal cancer survivors. Amercian Journal of Cancer Research, 2022; ( IF,6.166)
27. Yao S, Yin X, Chen T, Chen W, Zuo H, Bi Z, Zhang X, Jing Y, Pang L, Cheng H. Exploring ALDH2 expression and immune infiltration in HNSC and its correlation of prognosis with gender or alcohol intake. Scientific Reports, 2022 15;12(1):2504. （IF, 4.379）
28. Song G, Zhang F and Cheng H. Thalidomide for prevention of camrelizumab-induced reactive cutaneous capillary endothelial proliferation. Australas J Dermatol，2022;63 (2):217-221. （IF, 2.857）
29. Yang Y, Huang JF, Hu BQ, Zhou J, Wang X, Feng ZZ, Chen YT, Pan FM, Cheng HD, Chen LW.B7-H3 is eligible for predicting clinical outcomes in lung adenocarcinoma patients treated with EGFR tyrosine kinase inhibitors, World J Surg Oncol. 2022,20(1):159.（IF, 3.253）
30. Li W, Yu S, Duan X, Yao S, Tang L, Cheng H. COMT rs737865 mediates chemobrain in breast cancer patients with various levels of Ki-67. Amercian Journal of Cancer Research, Am J Cancer Res. 2022 Jul 15;12(7):3185-3197.（IF,6.166）
31. Sheng Yu,Jingjing Zhao,Menglian Wang,Wen Li,Lingxue Tang,Senbang Yao,Lulian Pang,Xiangxiang Yin,Yanyan Jing and Huaidong Cheng, The correlation between NLR, CEA and CA153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients, Frontiers in Medicine, 2022，(IF, 5.058）
32. Wen Li,Yue Lv,XU Duan,Senbang Yao,Sheng Yu,Lingxue Tang and Huaidong Cheng, The alterations in event-related potentials (ERP) response to pain empathy in breast cancer survivors treated with chemotherapy,Frontiers in Psychology, 2022 (IF, 4.232）
33. Yao S, He Zuo, Cheng H,The correlations between psychological distress, cognitive impairment and quality of life in patients with brain metastases after whole-brain radiotherapy, Clinical and Translational Oncology, 2022，（IF, 3.340）
34. Yin X, Cheng H. Fear of cancer recurrence is related to the efficacy of immunotherapy and quality of life in patients with NSCLC during the COVID-19 pandemic in China, Amercian Journal of Cancer Research, 2022.（IF,6.166）
35. Lingxue Tang, Sheng Yu, Qianqian Zhang, Cai Yinlian, Wen Li, Senbang Yao and Huaidong Cheng, Identification of hub genes related to CD4 + memory T Cell infiltration with gene co-expression network predicts prognosis and immunotherapy effect in colon cancer, Frontiers in Genetics , 2022，（IF, 4.772）
36. Lingxue Tang, Huaidong Cheng et.al Construction of cuproptosis-related lncRNAs/mRNAs model and prognostic prediction of hepatocellular carcinoma, , Amercian Journal of Cancer Research, 2022 （IF,6.166）
37. Yao S, Wen Li, Cheng H, Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy-related cognitive impairment in patients with breast cancer who receive chemotherapy, Cancer Medicine , 2022, （IF,4.771）
38.Yao S, Chen W, Zuo H, Bi Z, Zhang X, Pang L, Jing Y, Yin X, Cheng H. Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma. Biochem Genet. 2021 Dec 20.（IF，2.220）
39. Pang L, Bi Z, Jing Y, Yin X, Zhang X, Yao S, Zhao J, Cheng H， Changes in cytokine levels in breast cancer patients with CRCI before or after CALM intervention. Am J Cancer Res. 2021,11(11):5415-5427.(IF，6.166）
40. Yao S, Yin X, Chen T, Chen W, Zuo H, Bi Z, Zhang X, Jing Y, Pang L, Cheng H. ALDH2 is a prognostic biomarker and related with immune infiltrates in HCC. Am J Cancer Res. 2021 Nov 15;11(11):5319-5337. (IF，6.166)
41. Jingjing Zhao, He Zuo,Ke Ding, Xiuqing Zhang, Ziran Bi, Huaidong Cheng，Changes in plasma IL-1β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients，Am J Transl Res, 2020,15;12(6):3046-3056. （IF 3.266）
42. Ke Ding, Xiuqing Zhang, Jingjing Zhao, He Zuo, Ziran Bi, Huaidong Cheng, Managing Cancer and Living Meaningfully(CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors, Integr Cancer Ther, 2020;19:1534735420938450（IF 2.933）
43. Li W, Zhao J, Ding K, Chao HH, Li CR, Cheng H, Shen L. Catechol-O-Methyltransferase GenePolymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression. Med Sci Monit, 2020,26: e923567. （IF 1.980）
44. Gan C, Lv Y, Zhao J, Chao HH, Li CR, Zhang C, Yu F, Cheng H*, Neural correlates.of chemotherapy-induced emotion regulation impairment in breast cancer patients, American Journal of Cancer Research, 2019,9(1):171-179.（IF 5.177）
45. Haijun Chen, Ke Ding, Jingjing Zhao, Herta H Chao, Chiang-Shan R Li, Huaidong Cheng*，The dorsolateral prefrontal cortex is selectively involved in chemotherapy-related cognitive impairment in breast cancer patients with different hormone receptor expression，American Journal of Cancer Research, 2019,9(8):1776-1785. （IF 5.177）
46. Zeng Y, Cheng ASK, Song T, Sheng X, Cheng H*, Qiu Y, Xie J, Chan CCH. Changes in functional brain networks and neurocognitive function in Chinese gynecological cancer patients after chemotherapy: a prospective longitudinal study. BMC Cancer. 2019, 25;19(1):386. （IF2.933）
47. Yingchun Zeng, Jun-E Zhang, Andy S. K. Cheng, Huaidong Cheng*, Meta-Analysis of the Efficacy of Virtual Reality–Based Interventions in Cancer-Related Symptom Management, Integrative Cancer Therapies, 2019,18:1-8. （IF 2.634）
48. Huang Z, Zhao J, Ding K, Lv Y, Zhang C, Chao HH, Li CS, Cheng H*. Depression involved in self-reported prospective memory problems in survivors of breast cancer who have received chemotherapy Medicine (Baltimore). 2019,98(16):e15301. （IF 1.870）
49. Qiu J, Cheng HD, Dong T, Xiang L, Wang M, Xia L, Wang K,Prospective memory impairment in patients with white matter lesions, Int J Neurosci, 2019,129(5):438-446. （IF 1.750）
50. Zhang B, Chen MY, Shen YJ, Zhuo XB, Gao P, Zhou FS, Liang B, Zu J, Zhang Q, Suleman S, Xu YH, Xu MG, Xu JK, Liu CC, Giannareas N, Xia JH, Zhao Y, Huang ZL, Yang Z, Cheng HD, Li N, Hong YY, Li W, Zhang MJ, Yu KD, Li G, Sun MH, Chen ZD, Wei GH, Shao ZM.ALarge-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel. Loci Predisposing to Breast Cancer, Cancer Research, 2018,78(11):3087-3097. （IF 9.130）
51. Li X, Chen H, Lv Y, Chao HH, Gong L, Li CR, Cheng H*, Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients, Sci Rep, 2018, 8 (1):13801（IF 4.122）
52. Chenchen Liu, Ying Liu, Lei Chen, Mingjun Zhang, Wei Li, Huaidong Cheng, Bo Zhang Quantitative proteome and lysine succinyome analyses provide insights into metabolic regulation in breast cancer, Breast Cancer.2019,26(1):93-105. （IF2.044）
53. Wang X, Lv Y, Li W, Gan C, Chen H, Liu Y, Chao HH, Li CR, Cheng H*, Correlation between Psychosocial Distress and Quality of Life in Patients with Nasopharyngeal Carcinoma following Radiotherapy, J Oncol, 2018,2018:3625302. （IF 4.528）
54. Yingying Liu1*, Yue Lv1*, Chen Gan1, Haijun Chen1, Herta H Chao2, Chiang-Shan R Li3, Zhendong Chen1, Huaidong Cheng*, Prospective memory and retrospective memory impairment in patients with nasopharyngeal carcinoma after radiotherapy, Int J Clin Exp Med, 2018;11(7):7240-7246（IF 0.833）
55.Cheng H#*, Chen H, Lv Y, Chen Z, Li CR, Prospective memory impairment following whole brain radiotherapy in patients with metastatic brain cancer, Cancer Med, 2018,7(10):5315-5321.（IF3.202;）
56.Cheng, Huaidong #* , Li Wen，Gong, Liang，Xuan, Han，Huang, Zhonglian，Zhao, Hong， Wang, Long Sheng ， Wang, Kai ， Altered resting-state hippocampal functional networks associated with chemotherapy-induced prospective memory impairment in breast cancer survivors, Scientific Reports, 2017.3.22 ,7（IF 4.122）
57. Huaidong Cheng#*, Xuan Han, Chen Gan, Li Wen，Zhendong Chen，Altered network efficiency of functional brain networks in patients with breast cancer after chemotherapy, Oncotarget， 2017.11.09. （IF 5.168）
58. Huaidong Cheng#*, Li, Wen ， Gan, Chen, The COMT (rs165599) gene polymorphism contribute chemotherapy-induced cognitive impairment in breast cancer patients, America Journal Translation Research, 2016.11.30 ,8(11)：5087~5097. （IF3.266）
59. Li, Wen，Gan, Chen，Lv, Yue，Wang, Shanghu，Cheng, Huaidong*，Chemotherapy-induced prospective memory impairment in breast cancer patients with different hormone receptor expression，Medicine，2017, 3 ,96(13). （IF 2.022）
60. Deng M, Wei L, Zuo X, Tian Y, Xie F, Hu P, Zhu C, Yu F, Meng Y, Wang H, Zhang F, Ma H, Ye R, Cheng H, Du J, Dong W, Zhou S, Wang C, Wang Y, Wang J, Chen X, Sun Z, Zhou N, Jiang Y, Liu X, Li X, Zhang N, Liu N, Guan Y, Han Y, Han Y, LvX, Fu Y, Yu H, Xi C, Xie D, Zhao Q, Xie P, Wang X, Zhang Z, Shen L, Cui Y, Yin X, Cheng H, Liang B, Zheng X, Lee TM, Chen G, Zhou F, Veldink JH, Robberecht W, Landers JE, Andersen PM, Al-Chalabi A, Shaw C, Liu C, Tang B, Xiao S, Robertson J, Zhang F, van den Berg LH, Sun L, Liu J, Yang S, Ju X, Wang K, Zhang X. Genome-wide association analyses in Han Chinese identify two new susceptibility loci foramyotrophic lateral sclerosis, Nature Genetics, 2013 45(6):697-700. （IF 35.209）
61. Huaidong Cheng#, Kai Wang, Zhendong Chen. Chemotherapy-induced prospective memory impairment in patients with Breast cancer. Psycho-Oncology, 2013, 22, 10, 2391-2395. （IF 4.044）
62. Gong, Liang，Wang, JiHua，Yang, XuDong，Feng, Lei，Li, Xiu，Gu, Cui，Wang, MeiHong， Hu, JiaYun ， Huaidong Cheng*, Dissociation between Conceptual and Perceptual Implicit Memory: Evidence from Patients with Frontal and Occipital Lobe Lesions, Frontiers in Human Neuroscience, 2016 ,13;9:722. （IF 3.209）
63. Xu, Yihui，Chen, Mengyun，Liu, Chenchen，Zhang, Xiaowei，Li, Wei，Zhu, Jun，Zhang, Mingjun，Chen, Zhendong,Zhang Bo, Cheng, Huaidong, Association Study Confirmed Three Breast Cancer-Specific Molecular Subtype-Associated Susceptibility Loci in Chinese Han Women, Oncologist, 2017,22(8)：890~894. （IF 5.252）
64.Chen, Xingui，He, Xiaoxuan，Tao, Longxiang，Cheng, Huaidong，Li, Jingjing，Zhang, Jingjie， Qiu, Bensheng，Yu, Yongqiang，Wang, Kai，The attention network changes in breast cancerpatients receiving neoadjuvant chemotherapy: Evidence from an arterial spin labeling perfusion studyThe attention network changes in breast cancer patients receiving neoadjuvant chemotherapy: Evidence from an arterial spin labeling perfusion study，Scientific Reports,2017.2.17（IF 4.122）
65. Xi, Chunhua，Zhu, Youling，Mu, Yanfang，Chen, Bing，Dong, Bin，Cheng, Huaidong，Hu, Panpan，Zhu, Chunyan, Wang,Kai, Theory of mind and decision-making processes are impaired in Parkinson's disease，Behavioural Brain Reseach, 2015.2.15 ,279:226~233. （IF 3.028）
66. Xu, Minggui，Xu, Yihui，Chen, Mengyun，li, Yang，li, Wei，Zhu, Jun，Zhang, Mingjun， Chen, Zhendong，Zhang, Xuejun，liu, Jianjun，Zhang, Bo，Association study confirms two susceptibility loci for breast cancer in Chinese Han women, Breast Cancer Research And Treatment, 2016.10 ,159(3)：433~442. （IF 3.626）
67. Dong, T.，Qiu, J.，Cheng, H. -D.，Dong, W. -W.，Huang, P.，Xu, C. -S.，Wang, K.，Yang,W. -M. ，Impairment of time-based prospective memory in patients with Wilson's disease, European Review For Medical And Pharmacological Sciences, 2016.520(9)：1845~1851.（IF，1.213）
68. Zhang, Mingjun，Chen, Zhendong，Yang, Yang，Cheng, Huaidong，Li, Chao，He, Qian， Pretreatment with different doses of dexamethasone in the prevention of docetaxel-induced hypersensitivity, Pakistan Journal Of Pharmaceutical Sciences, 2017.1 ,30(1)：61~65. （IF 0.649）
69. Wang N, Zhang M, Sun T, Cheng H, Huang Z, Yan L, Wang L, Li F, Chen Z. A comparative study: diffusion weighted wholebody imaging with background body signal suppression and hybrid Positron Emission Computed Tomography on detecting lesions in oncologic clinics. Eur J Radiol, 2012，81(7):1662-6. （IF 2.606）
70. Yanghua Tian, Ling Wei, Chenyou Wang, Huaidong Cheng, Shenchun Jin Yongguang Wang,Kai Wang. Dissociation between visual line bisection and mental number line bisection in schizophrenia. Neuroscience Letters, 2011,491: 192-195. （IF 2.055）
71. Liang Gong, Yanghua Tian, Huaidong Cheng, Zhendong Chen, Changlin Yin, Yu Meng, Rong Ye, Kai Wang Conceptual implicit memory impaired in amentia mild cognitive impairment patient, Neuroscience Letters, 2010, 484:153–156. （IF2.055）
72. Huaidong Cheng#, Yanghua Tian, Panpan Hu, Junjun Wang, and Kai Wang. Time based prospective memory impairment in patients with thalamic stroke. Behavioral Neuroscience,2010,124 (1):152-158. （IF 2.874）
73. Huaidong Cheng#, Kai Wang, Chun-hua Xi, Chao-shi Niu, Xian-Ming Fu. Prefrontal cortex involvement in the event-based prospective memory: evidence from patients with lesions to prefrontal cortex. Brain Injury, 2008, 22 (9):697-704. （IF 1.250）